MedPath

Comparative study of the sustained erythropoiesis-stimulating agents in patients with chronic kidney disease at predialysis stage

Not Applicable
Conditions
chronic kidney disease
Registration Number
JPRN-UMIN000008531
Lead Sponsor
Division of Nephrology, Hypertension and Endocrinology, Itabashi Hospital, Nihon University School of Medicn
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

The patients who received transfusion within the past 24 weeks The patients who refused subcutaneous injection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath